Non-enzymatic protein targeting agents as a promising strategy for cancer treatment
Increased research attention has been brought to non-enzymatic protein targeting agents as a new and effective strategy for advancing cancer treatment. To discover this class of new anticancer drugs, two molecular approaches targeting the non-enzymatic activities of proteins have shown promising exp...
Saved in:
Main Authors: | Madison Ambrose, Jeremy Lee, Aleem Syed, Zamal Ahmed, Guang Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Drug Discovery |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fddsv.2025.1520734/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influenza A virus hemagglutinin: from classical fusion inhibitors to proteolysis targeting chimera-based strategies in antiviral drug discovery
by: Francisco Javier Hermoso-Pinilla, et al.
Published: (2024-02-01) -
PROTACs: Mechanism and Bioavailability enhancement strategies by nanotechnology, RNA viral infections (vaccine strategy) and Prodrug development
by: Sanaul Mustafa, et al.
Published: (2025-01-01) -
A Primer on the Role of TP53 Mutation and Targeted Therapy in Endometrial Cancer
by: Bohao Zhang, et al.
Published: (2025-01-01) -
New strategies to enhance the efficiency and precision of drug discovery
by: Qi An, et al.
Published: (2025-02-01) -
Potential drug targets for asthma identified through mendelian randomization analysis
by: Xingxuan Chen, et al.
Published: (2025-01-01)